METHYLPREDNISOLONE | N011153 | PFIZER INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Jubilant Generics Limited FDA-2017-P-2129 · 6 docket documents Jubilant Generics Limited filed this citizen petition pursuant to section 505(j)(2)(c) of the Federal Food, Drug and Cosmetic Act requesting that the FDA determine Methylprednisolone Tablets at strengths of 12 mg, 20 mg, and 28 mg are suitable for submission as an Abbreviated New Drug Application, w | Other | 2017-04-05 | Withdrawn | Jubilant Generics Limited |
Lachman Consultant Services, Inc. - Citizen Petition FDA-2009-P-0180 · 3 docket documents This document appears to be a printout from the FDA's Orange Book database showing active ingredient search results for prednisolone and methylprednisolone products, listing various approved applications, dosage forms, strengths, and manufacturers. However, the document itself does not contain the a | Other | 2009-04-10 | Granted | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$2.91
per ea
Lowest NADAC/Unit
$0.1124
per ea
Brand NDCs
2
Generic NDCs
5
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 59762005101METHYLPREDNISOLONE 32 MG TAB | $2.91 | EA | Generic | — | 2026-06-17 |
| 59762005001METHYLPREDNISOLONE 16 MG TAB | $1.37 | EA | Generic | — | 2026-06-17 |
| 59762004901METHYLPREDNISOLONE 8 MG TABLET | $1.02 | EA | Generic | — | 2026-06-17 |
| 00009005604MEDROL 4 MG DOSEPAK | $0.2909 | EA | Brand | $0.1124 | 2026-06-17 |
| 00009005602MEDROL 4 MG TABLET | $0.2257 | EA | Brand | $0.1244 | 2026-06-17 |
| 59762444003METHYLPREDNISOLONE 4 MG TABLET | $0.1244 | EA | Generic | — | 2026-06-17 |
| 59762444002METHYLPREDNISOLONE 4 MG DOSEPK | $0.1124 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.